Why Do Your Breasts Hurt So Much? TheYearOfTheBoob.com

New Post Public Reply Private Reply Replies (0) Message Board
Whos_Who
Why Do Your Breasts Hurt So Much?

TheYearOfTheBoob.com generates awareness for a seldom-discussed women's health issue, encouraging women to stop putting up with "PMS breasts"


MENLO PARK, Calif., April 6, 2016 /PRNewswire/ -- The facts are eye-opening at best and shocking at worst: Every month, 72% of women suffer sore, achy breasts with their menstrual cycles1 according to a survey conducted on behalf of BioPharmX. Some are not able to exercise, be intimate with their partners, or even hug their children due to the discomfort. Yet, 45% of these women do not seek a solution from their doctors because they think that breast tenderness "is simply part of being a woman."2

To shed light on the problem of monthly breast discomfort (or "PMS breasts" and spotlight the solution, the newly launched "The Year of The Boob" content hub aims to start an open conversation about the good, the bad, and the funny aspects of the almighty boob. This includes inviting and empowering women to learn what's going on inside their breasts—and how to seek relief. The hub's content includes a "woman on the street" video series (playfully titled "Boob on the Street", women's health tips, articles and research. There's also plenty of pop culture humor and entertainment – and plans for more user-generated content that centers on the trials and tribulations of being a woman. It's all an effort to actively engage women across the board, while raising awareness about both the issue and the solution to menstrual-related breast discomfort.

For many women, PMS breasts are linked to the hormonal fluctuations of their menstrual cycle. For others, the culprit is the otherwise benign fibrocystic breast condition (FBC). The result is the same: For several days or even weeks every month, women are forced to compromise their regular routines, including missing exercise, school and/or work; for some, the discomfort is so bad, they are unable to hug their children and/or be intimate with their partners.

Ellen Williams of Bricktown, New Jersey quit playing volleyball, stopped going on runs, hated the idea of having to walk up or down stairs and wouldn't let her boyfriend near her breasts during "that time of the month." Despite her fit physique, she wore baggy clothes or sweatshirts all the time because she didn't even want to think about her breasts.

"These conditions affect millions of women, yet very few specifically ask about ways to treat the problem at its source—most women view the discomfort as a normal occurrence that they simply have to accept," explains Dr. Lee Shulman, OBGYN at the Feinberg School of Medicine. "By taking Violet iodine every day millions of women need not suffer from the severe breast tenderness that comes with a woman's menstrual cycle."

Violet iodine—a non-hormone supplement that is available without a prescription—is created using a novel technology that combines a patented formulation of two forms of iodine: iodide and iodate. This unique formulation interacts with the acidic pH environment of the stomach to form molecular iodine, which is then delivered directly to breast tissue, resulting in a reduction of menstrual-related breast discomfort. Until now, there has never been a supplement demonstrated to target breast tissue, making Violet iodine the first iodine supplement to address the underlying cause of menstrual-related breast symptoms.

Ellen Williams' doctor recommended that she try molecular iodine. Now, Ellen is back on the volleyball court and back to her running routine. As Ellen explains, "Sometimes I forget how much the [molecular] iodine is helping me until I forget to take it. Just a few days without it, and I really feel the pain again."3

About Violet® iodine

Violet iodine is produced by BioPharmX, a specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in the health and wellness markets, including dermatology and women's health.

1 This survey was conducted online within the United States by Harris Poll on behalf of BioPharmX from January 7-11, 2016 among 582 adult women ages 18-49.

2 This survey was conducted online within the United States by Harris Poll on behalf of BioPharmX from July 31-August 5, 2015 among 985 adult women ages 25 and older.

3 Individual results may vary. Some women experience relief with their first menstrual cycle, however, initial symptom relief may take 60 days or longer."

SOURCE BioPharmX

For further information: Nina Brauer, nbrauer@biopharmx.com, (650) 889-5030

BioPharmX Corporation (BPMX) Stock Research Links

BPMX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 1

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 11

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 15

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 14

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 9

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 11

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading

Top 5 Most Recently Viewed Articles

Verkkokauppa.com Oyj Enhances Shareholder Value Through Buyback

Updated Category News Views 147

Verkkokauppa.com Oyj Enhances Shareholder Value In a significant move to bolster investor confidence, Verkkokauppa.com Oyj has completed an acquisition of its own shares. This strategic initiative reflects the company’s commitment to returning value to its shareholders. Details of the Share Acquisition The company's recent transaction involved acquiring 17,400 shares at...

Continue Reading
Understanding Qualys's Short Interest and Market Trends

Updated Category News Views 142

Qualys Short Interest Analysis Qualys Inc. (NASDAQ: QLYS) has recently seen a notable increase in the short percent of its float, which has risen by 6.4%. As per the latest reports, there are approximately 2.95 million shares currently sold short, representing 11.3% of all available regular shares for trading. This figure indicates that, at the present trading volume, it...

Continue Reading
Signature Aviation Launches Exciting New Private Terminal

Updated Category News Views 327

Signature Aviation Expands Private Aviation Services Signature Aviation, renowned as the world’s largest private aviation terminal network, proudly announces the successful completion of the first phase of its new facility at Savannah/Hilton Head International Airport. This development is set to revolutionize private aviation experiences with a modern terminal that...

Continue Reading
AISpeech's MA600D Stars at InfoComm Asia 2026

Updated Category News Views 18

Sound and Fury at InfoComm Asia 2026 Kicking off the tech buzz in Bangkok, the InfoComm Asia 2026 has thrown AV enthusiasts and Southeast Asia's system integrators into the pheromone-infused Queen Sirikit National Convention Center. Amongst the cavalcade of audio warriors stands the AISpeech MA600D Matrix Array Microphone—effortlessly stealing the show at the event’s...

Continue Reading
Sagamore Spirit Celebrates Community as Whiskey Sponsor of Golf

Updated Category News Views 210

Sagamore Spirit Embraces Community Spirit as Whiskey Sponsor Sagamore Spirit, the renowned whiskey distillery, is thrilled to announce its role as the Preferred Whiskey Provider for the prestigious 2025 BMW Championship. This exciting event is set to gather golf enthusiasts and highlight the best talents in the sport. The championship will unfold at Caves Valley Golf Club...

Continue Reading